Merrimack discontinues development of MM-310 owing to cumulative peripheral neuropathy in phase I April 5, 2019
Small-molecule PD-L1 inhibitor MAX-10181 shows similar antitumor efficacy to durvalumab in mice April 5, 2019
Anti-BSP fused to CPPs shows antimetastatic potential in preclinical breast cancer models April 5, 2019
RSS